MedTrace Logo

A Cardiac Registry to Evaluate and Manage the hsTnI Categorical CVD Risk in Subjects Undergoing Preventive Health Checks (PHC).

NCT04903041 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 300000

Last updated 2025-11-28

No results posted yet for this study

Summary

Cardiovascular disease is the leading cause of mortality globally. In India cardiovascular disease leads to death a decade earlier than in western countries. In the past 20 years awareness and classic risk factors and statins have been the main improvements. However, all these factors have not decreased the cardiovascular disease burden. One reason may be because all of the current assessments for cardiac risk are correlants to disease and none are specific to cardiac myocyte status.

Conditions

Sponsors & Collaborators

  • Apollo Hospitals Enterprise Limited

    collaborator OTHER

  • Jaime Marino

    lead INDUSTRY

Principal Investigators

  • Pratap C Reddy, MD · Apollo Hopsitals

  • Hari Prasad, MD · Apollo Hospitals Enterprise Limited

  • Abraham Oomman, MD · Apollo Hospitals Enterprise Limited

  • Padma Madala, MD · Apollo Hospitals Enterprise Limited

  • Jaganathan Sickan, MD · Abbott

  • Agim Beshiri, MD · Abbott

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-12
Primary Completion
2029-09-12
Completion
2030-09-12

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04903041 on ClinicalTrials.gov